Janus Henderson Group PLC Sells 1,172,600 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Janus Henderson Group PLC lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 15.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,389,767 shares of the medical instruments supplier's stock after selling 1,172,600 shares during the quarter. Janus Henderson Group PLC owned about 3.21% of DENTSPLY SIRONA worth $172,907,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. UMB Bank n.a. lifted its position in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $27,000. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after buying an additional 564 shares during the period. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $32,000. Finally, Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $35,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. UBS Group cut their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday. Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday, November 8th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Tuesday, November 19th. Leerink Partners downgraded shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday, November 7th. Finally, Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research note on Friday, November 8th. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of "Hold" and a consensus price target of $28.40.

DENTSPLY SIRONA Trading Up 0.4 %

Shares of XRAY traded up $0.07 during midday trading on Wednesday, hitting $19.46. The stock had a trading volume of 2,022,343 shares, compared to its average volume of 3,109,484. DENTSPLY SIRONA Inc. has a fifty-two week low of $17.21 and a fifty-two week high of $37.60. The business has a 50-day simple moving average of $22.17 and a two-hundred day simple moving average of $24.59. The firm has a market cap of $3.87 billion, a P/E ratio of -9.40, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same quarter last year, the firm earned $0.49 earnings per share. The company's revenue for the quarter was up .4% on a year-over-year basis. As a group, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.